https://doi.org/10.4081/hmr.v1i5.262

Epidemiology of hepatitis C virus in lymphomas

Vol. 1 No. 5: International Symposium on Infection-Driven Lymphomas, Rome, April 17-19, 2005
Published: May 29, 2009
Abstract Views: 166
PDF: 272
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Alfonso Mele
support@pagepress.org
Hepatitis C virus (HCV) is an RNA virus and is a member of the Flaviviridae family. It is the most common cause of sporadic non-A non-B and post-transfusion hepatitis (Kuo et al, 1989) and a major cause of chronic liver diseases, including liver cirrhosis and hepatocellular carcinoma. In addition to the direct liver injury, various extrahepatic manifestations includine autoimmune disorders, glomerular injury, vasculitis, sicca syndrome, and type-II cryoglobulinemia (MCII) may occur in these patients. MCII is a systemic vasculitis often characterized as “benign” B-cell proliferation that evolves into B-cell non-Hodgkin lymphoma (B-NHL) in 8-10% of affected cases. An estimated 40-100% of patients with MCII are chronically infected with HCV (Agnello et al, 1992; Pozzato et al, 1994). This finding led to the hypothesis that HCV may play a role in lymphomagenesis, and several studies have investigated the potential association between HCV infection and B-NHL, whether related or not to MCII. Results of these studies have been conflicting.

Dimensions

Altmetric

PlumX Metrics

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC

Supporting Agencies

How to Cite

Mele, A. (2009). Epidemiology of hepatitis C virus in lymphomas. Hematology Meeting Reports (formerly Haematologica Reports), 1(5). https://doi.org/10.4081/hmr.v1i5.262
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).